Key Abstracts in COPD From CHEST 2022

Nicola A. Hanania, MD


November 09, 2022

Dr Nicola Hanania from Baylor University discusses key findings in chronic obstructive lung disease (COPD) presented at the CHEST 2022 annual meeting. He begins with the results of a study that evaluated the frequency of spirometry testing in patients with a diagnosis of COPD, and that also examined racial differences and disparities in spirometry administration.

Dr Hanania also highlights a study that evaluated the risk of COPD severity among Medicare patients who had moderate exacerbations or no exacerbations as baseline. The study found that patients at high risk of severe exacerbations were those with moderate-to-severe exacerbations during the preceding year, but those with no exacerbation had a higher risk of being hospitalized.

Next, Dr Hanania examines the first US randomized controlled trial looking at home rehabilitation of COPD patients. The findings indicated that home pulmonary rehabilitation facilitated by remote health coaching may improve several domains of quality of life, including improvement in self management, sleep, and depression symptoms.

Finally, Dr Hanania shares the results of a study which found that delaying initiation of triple therapy following a second moderate exacerbation among U.S. COPD patients was associated with increased occurrence of future exacerbation, including severe exacerbation, while prompt initiation was associated with lower exacerbation, and lower total exacerbation, as well as fewer severe exacerbations.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.